| Association between vitamin D supplementation and COVID-19 infection and mortality JB Gibbons, EC Norton, JS McCullough, DO Meltzer, J Lavigne, ... Scientific reports 12 (1), 19397, 2022 | 59 | 2022 |
| Methadone on wheels—a new option to expand access to care through mobile units JB Gibbons, EA Stuart, B Saloner JAMA psychiatry 79 (3), 187-188, 2022 | 20 | 2022 |
| The association between vitamin D serum levels, supplementation, and suicide attempts and intentional self-harm JE Lavigne, JB Gibbons Plos one 18 (2), e0279166, 2023 | 16 | 2023 |
| Increasing overdose deaths among Black Americans: a review of the literature JB Gibbons, SJ Harris, KT Solomon, O Sugarman, C Hardy, B Saloner The Lancet Psychiatry 10 (9), 719-726, 2023 | 9 | 2023 |
| Association between buprenorphine treatment gaps, opioid overdose, and health care spending in US Medicare beneficiaries with opioid use disorder JB Gibbons, JS McCullough, K Zivin, ZY Brown, EC Norton JaMa Psychiatry 79 (12), 1173-1179, 2022 | 9 | 2022 |
| The social vulnerability metric (SVM) as a new tool for public health L Saulsberry, A Bhargava, S Zeng, JB Gibbons, C Brannan, ... Health Services Research 58 (4), 873-881, 2023 | 8 | 2023 |
| Humira: The First $20 Billion Drug. JB Gibbons American Journal of Managed Care, NA-NA, 2023 | 7 | 2023 |
| A Global Equity Model (GEM) for the Advancement of Community Health and Health Equity AC Offodile, JB Gibbons, S Murrell, D Kinzer, JM Sharfstein NAM perspectives 2022, 2022 | 4 | 2022 |
| Association between hospital adoption of an emergency department treatment pathway for opioid use disorder and patient initiation of buprenorphine after discharge KT Solomon, J O’Connor, JB Gibbons, AS Kilaru, KA Feder, L Xue, ... JAMA Health Forum 4 (3), e230245-e230245, 2023 | 3 | 2023 |
| Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare JB Gibbons, JS McCullough, K Zivin, ZY Brown, EC Norton Journal of Substance Use and Addiction Treatment 157, 209271, 2024 | 2 | 2024 |
| Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry K Ahn, A Trujillo, J Gibbons, CL Bennett, G Anderson International Review of Law and Economics 76, 106169, 2023 | 2 | 2023 |
| The impact of nurse practitioner care and accountable care organization assignment on skilled nursing services and hospital readmissions J Meddings, JB Gibbons, BK Reale, M Banerjee, EC Norton, JPW Bynum Medical care 61 (6), 341-348, 2023 | 2 | 2023 |
| Mitigating algorithmic bias in opioid risk-score modeling to ensure equitable access to pain relief AM Bhagwat, KS Ferryman, JB Gibbons Nature medicine 29 (4), 769-770, 2023 | 2 | 2023 |
| Congressional investigation of RevAssist-linked and general pricing strategies for lenalidomide CL Bennett, JB Gibbons, A Trujillo, KR Carson, K Knopf, C Nabhan, ... JCO Oncology Practice, OP. 23.00579, 2024 | 1 | 2024 |
| Comparison of social determinants of health in Medicaid vs commercial health plans JB Gibbons, P Cram, MK Meiselbach, GF Anderson, G Bai Health Affairs Scholar 1 (6), qxad074, 2023 | 1 | 2023 |
| Associations between insomnia medications and risk of death by suicide JE Lavigne, K Hur, JB Gibbons, WR Pigeon Sleep Medicine 111, 199-206, 2023 | 1 | 2023 |
| How Emergency Departments Are Responding to the Opioid Crisis: Results from a Statewide Survey in Kentucky O Sugarman, S Harris, L Byrne, V Flanagan, S Gattine, IK Desai, ... 2024 Annual Research Meeting, 2024 | | 2024 |
| Piloting racial bias training for hospital emergency department providers treating patients with opioid use disorder JB Gibbons, SJ Harris, OK Sugarman, EG Hulsey, J Rwan, EM Rosner, ... Health Affairs Scholar 2 (5), qxae049, 2024 | | 2024 |
| Adjusting Starting Points for Initial Price Offers: The Example of Ibrutinib. JB Gibbons, CL Bennett, KR Carson, GF Anderson American Journal of Managed Care 30 (4), 2024 | | 2024 |
| LocalTweets to LocalHealth: A Mental Health Surveillance Framework Based on Twitter Data V Deshpande, M Lee, Z Yao, Z Zhang, JB Gibbons, H Yu arXiv preprint arXiv:2402.13452, 2024 | | 2024 |
